Skip to main content
Erschienen in: Journal of Public Health 4/2008

01.08.2008 | Original Article

The expected impact of new vaccines and vaccination policies

verfasst von: Paolo Bonanni, Sara Boccalini, Angela Bechini

Erschienen in: Journal of Public Health | Ausgabe 4/2008

Einloggen, um Zugang zu erhalten

Abstract

Aim

The purpose of this paper is to outline the potential of newly available vaccines and highlight the evolution of tools required for correctly assessing the impact of immunisation policies.

Subjects and methods

We review an entire range of critical factors in the evaluation of the impact of new vaccines and vaccinations, including herd immunity, immunological memory, epidemiology and indirect effects of immunisation on vaccine-preventable diseases and illnesses.

Results

The impact of newer vaccines on public health has become as complex as it is promising: the benefits of vaccinating according to aged-based rather than at-risk-based recommendations (e.g. influenza vaccine); societal benefits going beyond the mere avoidance of death and hospitalisation (e.g. rotavirus vaccine); prevention of associated pathological states, of many confirmatory tests following a positive result of screening and psychological distress (e.g. human papillomavirus vaccine); or reduction of serious sequelae and associated chronic suffering (e.g. zoster vaccine).

Conclusion

The changing context of vaccinology offers new challenges for research methods and orientations. Clearly, we must shift from the concept of prevention of disease to that of prevention of illness. Developing tools for the precise measurement of these phenomena involves multidisciplinary co-operation in the development of dynamic models; at the same time, we must improve our communication skills for explaining complex issues to the larger public.
Literatur
Zurück zum Zitat Boncompagni G, Incandela L, Bechini A, Giannini D, Cellini C, Trezzi M, Ciofi degli Atti ML, Ansaldi F, Valle L, Bonanni P (2006) Measles outbreak in Grosseto, central Italy. Euro Surveill 11(8):E060803.4PubMed Boncompagni G, Incandela L, Bechini A, Giannini D, Cellini C, Trezzi M, Ciofi degli Atti ML, Ansaldi F, Valle L, Bonanni P (2006) Measles outbreak in Grosseto, central Italy. Euro Surveill 11(8):E060803.4PubMed
Zurück zum Zitat Brown RE, Breugelmans JG, Theodoratou D, Bénard S (2006) Costs of detection and treatment of cervical cancer, cervical dysplasia and genital warts in the UK. Curr Med Res Opin 22:663–670PubMedCrossRef Brown RE, Breugelmans JG, Theodoratou D, Bénard S (2006) Costs of detection and treatment of cervical cancer, cervical dysplasia and genital warts in the UK. Curr Med Res Opin 22:663–670PubMedCrossRef
Zurück zum Zitat Centers for Disease Control and Prevention (CDC) (2005) Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease—United States, 1998–2003. MMWR Morb Mortal Wkly Rep 54(36):893–897 Centers for Disease Control and Prevention (CDC) (2005) Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease—United States, 1998–2003. MMWR Morb Mortal Wkly Rep 54(36):893–897
Zurück zum Zitat Chidiac C, Bruxelle J, Daures JP, Hoang-Xuan T, Morel P, Leplège A, El Hasnaoui A, de Labareyre C (2001) Characteristics of patients with herpes zoster on presentation to practitioners in France. Clin Infect Dis 33:62–69PubMedCrossRef Chidiac C, Bruxelle J, Daures JP, Hoang-Xuan T, Morel P, Leplège A, El Hasnaoui A, de Labareyre C (2001) Characteristics of patients with herpes zoster on presentation to practitioners in France. Clin Infect Dis 33:62–69PubMedCrossRef
Zurück zum Zitat Edmunds WJ, Brisson M, Rose JD (2001) The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales. Vaccine 19:3076–3090PubMedCrossRef Edmunds WJ, Brisson M, Rose JD (2001) The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales. Vaccine 19:3076–3090PubMedCrossRef
Zurück zum Zitat Giaquinto C, Van Damme P, Huet F, Gothefors L, Van der Wielen M, REVEAL Study Group (2007) Costs of community-acquired pediatric rotavirus gastroenteritis in 7 European countries: the REVEAL Study. J Infect Dis 195(Suppl 1):S36–S44PubMedCrossRef Giaquinto C, Van Damme P, Huet F, Gothefors L, Van der Wielen M, REVEAL Study Group (2007) Costs of community-acquired pediatric rotavirus gastroenteritis in 7 European countries: the REVEAL Study. J Infect Dis 195(Suppl 1):S36–S44PubMedCrossRef
Zurück zum Zitat Maciosek MV, Coffield AB, Edwards NM, Flottemesch TJ, Goodman MJ, Solberg LI (2006) Priorities among effective clinical preventive services: results of a systematic review and analysis. Am J Prev Med 31:52–61PubMedCrossRef Maciosek MV, Coffield AB, Edwards NM, Flottemesch TJ, Goodman MJ, Solberg LI (2006) Priorities among effective clinical preventive services: results of a systematic review and analysis. Am J Prev Med 31:52–61PubMedCrossRef
Zurück zum Zitat Miller HC, Stephan M (1993) Hemorrhagic varicella: a case report and review of the complications of varicella in children. Am J Emerg Med 11:633–638PubMedCrossRef Miller HC, Stephan M (1993) Hemorrhagic varicella: a case report and review of the complications of varicella in children. Am J Emerg Med 11:633–638PubMedCrossRef
Zurück zum Zitat Nichol K, Treanor JJ (2006) Vaccines for seasonal and pandemic influenza. J Infect Dis 194(Suppl 2):S111–S118PubMedCrossRef Nichol K, Treanor JJ (2006) Vaccines for seasonal and pandemic influenza. J Infect Dis 194(Suppl 2):S111–S118PubMedCrossRef
Zurück zum Zitat Opstelten W, Mauritz JW, de Wit NJ, van Wijck AJ, Stalman WA, van Essen GA (2002) Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database. Fam Pract 19:471–475PubMedCrossRef Opstelten W, Mauritz JW, de Wit NJ, van Wijck AJ, Stalman WA, van Essen GA (2002) Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database. Fam Pract 19:471–475PubMedCrossRef
Zurück zum Zitat Van Damme P, Giaquinto C, Huet F, Gothefors L, Maxwell M, Van der Wielen M, REVEAL Study Group (2007) Multicenter prospective study of the burden of rotavirus acute gastroenteritis in Europe, 2004–2005: the REVEAL study. J Infect Dis 195(Suppl 1):S4–S16PubMedCrossRef Van Damme P, Giaquinto C, Huet F, Gothefors L, Maxwell M, Van der Wielen M, REVEAL Study Group (2007) Multicenter prospective study of the burden of rotavirus acute gastroenteritis in Europe, 2004–2005: the REVEAL study. J Infect Dis 195(Suppl 1):S4–S16PubMedCrossRef
Metadaten
Titel
The expected impact of new vaccines and vaccination policies
verfasst von
Paolo Bonanni
Sara Boccalini
Angela Bechini
Publikationsdatum
01.08.2008
Verlag
Springer-Verlag
Erschienen in
Journal of Public Health / Ausgabe 4/2008
Print ISSN: 2198-1833
Elektronische ISSN: 1613-2238
DOI
https://doi.org/10.1007/s10389-008-0203-z

Weitere Artikel der Ausgabe 4/2008

Journal of Public Health 4/2008 Zur Ausgabe